Le Lézard
Classified in: Science and technology
Subject: Personnel

Healthmine Appoints Maureen Sullivan, Former Blue Cross Blue Shield Association Executive, to Advisory Board


Healthmine, a leader in technology-enabled member engagement solutions, announces Maureen Sullivan, President of Balestrand Strategic Advisors, as a new member of the Advisory Board.

Sullivan brings 37 years of leadership experience at the Blue Cross Blue Shield Association, most recently as Chief Strategy and Innovation Officer. Sullivan led major strategic initiatives including developing national solutions to strengthen the Medicare Advantage business. She also worked with leadership across the Blues Association to develop CivicaScript to bring affordable generics to the market, BHI to enhance data leadership, and GeoBlue to provide expat coverage. Sullivan serves on multiple advisory boards where she helps companies leverage new growth opportunities and strengthen their strategic positioning.

"Healthmine's commitment to improving the member's experience and delivering measurable results for health plans stands out in the industry," said Sullivan. "The team is at the forefront of developing key partnerships that enhance the service offerings. Having worked closely with the team, I am impressed with their passion and innovative thinking."

Healthmine's Advisory Board provides the organization with a diverse range of thoughts, opinions and expertise from across the healthcare industry. Sullivan's appointment to the Board will further facilitate Healthmine's delivery of robust and comprehensive experiences to health plan partners and their members.

"We are excited to add Maureen's guidance and expertise to our Advisory Team," said Bryce Williams, Chief Executive Officer and President of Healthmine. "Her insights into healthcare strategies and the knowledge she collected at the Blue Cross Blue Shield Association will ensure our products continue to meet the needs of health plan operators."

Learn more about Healthmine's leadership team.

About Healthmine

Healthmine is the industry's leading member engagement solution focused on empowering people to take the right actions to improve their health and achieve a health plan's operational targets. We build personalized, ongoing member engagement strategies for health plans in all lines of business. Our SaaS-based, always-on Quality Relationship Management (QRM®) platform drives care gap closure with customized triggers based on clinical, pharmacy, CAHPS and HOS measures. When paired with intelligent incentives, plans see accelerated results in health equity and member outcomes while better managing medical spend. In addition, Healthmine clients have transparency into real-time, actionable insights on the success of member engagement and satisfaction initiatives, and the ability to bridge quality and risk efforts to better identify and prioritize areas of opportunity. With Healthmine, plans gain access to a comprehensive solution to improve on specific quality measures, meet ongoing regulatory changes and improve Star Ratings. Connect with us at Healthmine.com and on our LinkedIn.


These press releases may also interest you

at 02:17
Fun88, a leading company in sports and entertainment, proudly announces its official title sponsorship with the Vizag Warriors for the Andhra Premier League (APL)....

at 02:10
KLab Inc., a leader in online mobile games, announced that its hit 3D action game Bleach: Brave Souls will be holding a Bleach: Brave Souls 9th Anniversary Bankai Live! on Sunday, July 14, 2024 from 18:30 (JST/UTC+9). See the original press release...

at 02:00
Azentio Software ("Azentio") - a leading end-to-end software company specializing in the BFSI sector, today announced the appointment of Aarthi Ramesh as Chief Customer Officer and Emma Foley as Chief Marketing Officer....

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

at 01:05
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) and Bel Group, today announced their long-term partnership to accelerate the food industry's transformation toward a more sustainable model. The companies will play a pivotal role in shaping...



News published on and distributed by: